Edward P. Cartwright

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

DKN-01 and atezolizumab as second- or third-line therapy in advanced oesophagogastric adenocarcinoma: the WAKING trial.

DKN-01 and atezolizumab as second- or third-line therapy in advanced oesophagogastric adenocarcinoma: the WAKING trial.

Journal: ESMO gastrointestinal oncology

Published: September 03, 2026

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Journal: ESMO open

Published: March 24, 2026

Persuasiveness of Public Health Communication During the COVID-19 Pandemic: Message Framing, Threat Appraisal, and Source Credibility Effects.

Persuasiveness of Public Health Communication During the COVID-19 Pandemic: Message Framing, Threat Appraisal, and Source Credibility Effects.

Journal: International journal of environmental research and public health

Published: October 12, 2024

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.

Journal: ESMO open

Published: December 20, 2023

Medical occupation preference under the influence of the COVID-19 pandemic: The role of risk and altruistic preferences.

Medical occupation preference under the influence of the COVID-19 pandemic: The role of risk and altruistic preferences.

Journal: Health economics

Published: September 23, 2022

Practitioner review: health anxiety in children and young people in the context of the COVID-19 pandemic.

Practitioner review: health anxiety in children and young people in the context of the COVID-19 pandemic.

Journal: Behavioural and cognitive psychotherapy

Published: August 25, 2020

An economic analysis of ransomware and its welfare consequences.

An economic analysis of ransomware and its welfare consequences.

Journal: Royal Society open science

Published: January 04, 2019

Is front-line checkpoint blockade ATTRACTIVE in advanced gastric cancer?

Is front-line checkpoint blockade ATTRACTIVE in advanced gastric cancer?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 01, 2019

Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.

Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.

Journal: The Journal of antimicrobial chemotherapy

Published: November 19, 2017

Reconstructing transmission trees for communicable diseases using densely sampled genetic data.

Reconstructing transmission trees for communicable diseases using densely sampled genetic data.

Journal: The annals of applied statistics

Published: April 05, 2016

Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults.

Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 01, 2015

Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?

Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?

Journal: The Journal of antimicrobial chemotherapy

Published: May 03, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026